Correlation of long-term results of imatinib in advanced gastrointestinal stromal tumors with next-generation sequencing results: Analysis of phase 3 SWOG intergroup trial S0033
- Michael C. Heinrich
- , Cathryn Rankin
- , Charles D. Blanke
- , George D. Demetri
- , Ernest Borden
- , Christopher W. Ryan
- , Margaret von Mehren
- , Martin E. Blackstein
- , Dennis A. Priebat
- , William D. Tap
- , Robert G. Maki
- , C. L. Corless
- , Jonathan A. Fletcher
- , Kouros Owzar
- , John J. Crowley
- , Robert S. Benjamin
- , Laurence H. Baker
- Oregon Health and Science University
- SWOG Statistical Center
- Harvard University
- Cleveland Clinic Foundation
- Fred A. Litwin Center for Cancer Genetics
- Washington Hospital Center
- Memorial Sloan-Kettering Cancer Center
- Northwell Health System
- Cold Spring Harbor Laboratory
- Brigham and Women's Hospital
- Duke University
- University of Texas Health Science Center at Houston
- University of Michigan, Ann Arbor
- Portland VA Medical Center
- VA Portland Veterans Health Care System
- Novartis
- Dana-Farber Cancer Institute
- University of Helsinki
- University of Turku
- Fox Chase Cancer Center
- R and D-19 3710 U.S. Veterans Hospital Rd
- R and D-19
- Statistical Center
- University of Arizona
- University of British Columbia
- British Columbia Cancer Agency
- Dana-Farber/Harvard Cancer Center
- Cancer and Leukemia Group B
- Dana-Farber/Partners CancerCare
- Massachusetts General Hospital Cancer Center
- University of Toronto
- Cornell University
- University of California at Los Angeles
- University of Pennsylvania
- Icahn School of Medicine at Mount Sinai
- Wake Forest University
- University of California at Davis
- Fred Hutchinson Cancer Research Center
- SW Oncology Group Statistical Center
- University of Maryland Cancer Center
- University of Kansas
- University of Texas MD Anderson Cancer Center
Research output: Contribution to journal › Article › peer-review
120
Scopus
citations